SCHEMBL703259

SCHEMBL703259

COc1cc(OCCN(C)C)ccc1/N=C1/NC(=O)/C(=C/c2cnc(NC(=O)C3CC3)s2)S1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
HSD11B1 P28845 1/20 0.37
HPGD P15428 2/20 0.36
PTPN11 Q06124 2/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
PSEN1 P49768 1/20 0.36
PSEN2 P49810 1/20 0.36
APH1B Q8WW43 1/20 0.36
NCSTN Q92542 1/20 0.36
APH1A Q96BI3 1/20 0.36
PSENEN Q9NZ42 1/20 0.36
HCRTR1 O43613 1/20 0.35
HCRTR2 O43614 1/20 0.35
ITK Q08881 2/20 0.35
PTP4A3 O75365 1/20 0.35
TXK P42681 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL649652 0.91 RNASEL (0.40) HSD11B1HPGD
SCHEMBL652415 0.91 MAPT (0.41) MEN1KMT2AL3MBTL1HPGDPOLB
SCHEMBL698337 0.91 PTPN7 (0.36) MEN1KMT2AHPGDPTPN11POLB
SCHEMBL651724 0.89 PTPN7 (0.44) MEN1KMT2AL3MBTL1HSD11B1HPGD
SCHEMBL653897 0.88 MAPT (0.40) MEN1KMT2AL3MBTL1HPGDPOLB
SCHEMBL653900 0.87 MAPT (0.45) MEN1KMT2AHPGDPTPN11POLB
SCHEMBL651683 0.86 MAPT (0.40) MEN1KMT2AL3MBTL1HPGDPOLB
SCHEMBL653370 0.84 MAPT (0.40) MEN1KMT2AL3MBTL1HPGDPTPN11
SCHEMBL649305 0.84 MAPT (0.43) MEN1KMT2AL3MBTL1HPGDPTPN11
SCHEMBL650979 0.83 MAPT (0.42) MEN1KMT2AL3MBTL1HPGDPTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2423204-A1 THIAZOLIDINONE DERIVATIVE SBI Biotech Co., Ltd. (JP) 2012-02-29 EP disclosed
US-8119812-B2 Thiazolidinone derivative SBI BIOTECH CO., LTD. (JP) 2012-02-21 US disclosed
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE SBI BIOTECH CO., LTD. (JP) 2011-08-04 US disclosed
WO-2010122979-A1 THIAZOLIDINONE DERIVATIVE SBIバイオテック株式会社 (JP) 2010-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE CDC7, CDK17, CDCA2 MEN1 1406/4885KMT2A 3437/4885L3MBTL1 2190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.